Posted in | News | Nanobusiness

Oxonica Signs Agreement to Sell Oxonica Energy Limited

Oxonica plc, the UK-based international nanomaterials group, has announced that it has signed an agreement to sell Oxonica Energy Limited to Energenics Holdings Pte Limited on terms whereby there has been a full and final settlement of all legal actions between the Group and Neuftec Limited.

Ronen Hazarika, CEO of Energenics, said, “We are delighted that the acquisition has successfully completed. This acquisition will deliver critical mass to our European fuel additive business and we look forward to integrating Oxonica Energy’s staff & customers into the Energenics family and also extending the range of energy saving products available to the customer base.”

Oxonica is a nanomaterials group with products already launched into international markets. The Group also generates licence and development revenue from activities in the UV protection, clinical diagnostics and security markets.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxonica Inc.. (2019, March 18). Oxonica Signs Agreement to Sell Oxonica Energy Limited. AZoNano. Retrieved on May 19, 2024 from https://www.azonano.com/news.aspx?newsID=13963.

  • MLA

    Oxonica Inc.. "Oxonica Signs Agreement to Sell Oxonica Energy Limited". AZoNano. 19 May 2024. <https://www.azonano.com/news.aspx?newsID=13963>.

  • Chicago

    Oxonica Inc.. "Oxonica Signs Agreement to Sell Oxonica Energy Limited". AZoNano. https://www.azonano.com/news.aspx?newsID=13963. (accessed May 19, 2024).

  • Harvard

    Oxonica Inc.. 2019. Oxonica Signs Agreement to Sell Oxonica Energy Limited. AZoNano, viewed 19 May 2024, https://www.azonano.com/news.aspx?newsID=13963.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.